Nyxoah SA (NYXH)
Nyxoah SA, a medical technology company, focuses on the development and commercialization of solutions to treat obstructive sleep apnea. Its lead solution is th...
- Open
- 1.400
- High
- 1.405
- Low
- 1.330
- Prev. Close
- 1.400
- Volume
- 183.60K
- Turnover
- 252.61K
- Avg Price
- 1.376
- Bid/Ask Ratio
- 2.46%
- Amplitude
- 5.36%
- 52wk High
- 6.875
- Volume Ratio
- 4.56
- Turnover Ratio
- 0.75%
Nyxoah SA Analyst Rating
View moreForecast & Rating
Sep 3, 2026Price forecast
$4.34223.80%
Forecast & RatingBuy
4analysts
- Strong buy50.00%
- Buy0.00%
- Hold50.00%
- Sell0.00%
- Strong sell0.00%
News
- Tip Ranks · 18 hours ago
Nyxoah Names Former CFO Loïc Moreau as Interim Finance Chief, Reaffirms 2026 Guidance
- StockTitan · 2 days ago, 12:01 PM
Nyxoah Announces Chief Financial Officer Transition | NYXH Stock News
- StockTitan · Sep 7 at 12:05 PM
Nyxoah Announces First Patient Implanted in BREATHE, the U.S. Post-Approval Study of the Genio® System | NYXH Stock News
